Wakefield D, McCluskey P
Laboratory of Ocular Immunology, School of Pathology, University of NSW, Australia.
Aust N Z J Ophthalmol. 1990 May;18(2):129-35. doi: 10.1111/j.1442-9071.1990.tb00603.x.
Inflammatory eye disease (IED) is often the most severe manifestation of Behçet's syndrome (BS). This disease is a common cause of uveitis in Mediterranean countries, the Middle East and Japan. In order to ascertain the prevalence of this disease in Australia, we reviewed the aetiology of patients attending our uveitis clinic over a five-year period. Twelve of 426 patients with inflammatory eye disease had definite Behçet's syndrome. Four patients had anterior uveitis, four had posterior uveitis, four had retinal vasculitis and one also had optic neuritis. Although inflammatory eye disease was the initial clinical feature of Behçet's syndrome in only three of our patients, it was the feature that led to a definite diagnosis in all but one patient. The inflammatory eye disease of Behçet's syndrome was characteristically recurrent and severe with significantly decreased vision in 10 eyes, cataracts in six eyes, macula oedema in four eyes and glaucoma in two eyes. We conclude that Behçet's syndrome is a rare cause of inflammatory eye disease in Australia and is unlikely to be recognised as a distinct clinical entity prior to the onset of ocular involvement. The visual prognosis of ocular inflammation in Behçet's syndrome remains guarded despite the use of a variety of immunosuppressive agents.
炎性眼病(IED)通常是白塞病(BS)最严重的表现形式。这种疾病是地中海国家、中东和日本葡萄膜炎的常见病因。为了确定该病在澳大利亚的患病率,我们回顾了在五年期间到我们葡萄膜炎诊所就诊患者的病因。426例炎性眼病患者中有12例确诊为白塞病。4例患有前葡萄膜炎,4例患有后葡萄膜炎,4例患有视网膜血管炎,1例还患有视神经炎。尽管在我们的患者中只有3例炎性眼病是白塞病的初始临床特征,但它是除1例患者外所有患者明确诊断的特征。白塞病的炎性眼病具有反复发作且严重的特点,10只眼视力显著下降,6只眼有白内障,4只眼有黄斑水肿,2只眼有青光眼。我们得出结论,白塞病在澳大利亚是炎性眼病的罕见病因,在眼部受累之前不太可能被识别为一种独特的临床实体。尽管使用了多种免疫抑制剂,白塞病眼部炎症的视觉预后仍然不容乐观。